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Abstract
Objective To assess the potential of a thermal
carbon dioxide (CO2) laser to explore antinociception
in pain-free cats.
Study design Experimental, prospective, blinded,
randomized study.
Animals Sixty healthy adult female cats with
a (mean  standard deviation) weight of
3.3  0.6 kg.
Methods Cats were systematically allocated to one
of six treatments: saline 0.2 mL per cat; morphine
0.5 mg kg1; buprenorphine 20 lg kg1; mede-
tomidine 2 lg kg1; tramadol 2 mg kg1, and ke-
toprofen 2 mg kg1. Latency to respond to thermal
stimulation was assessed at baseline and at intervals
of 15–30, 30–45, 45–60, 60–75, 90–105 and 120–
135 minutes. Thermal thresholds were assessed
using time to respond behaviourally to stimulation
with a 500 mW CO2 laser. Within-treatment differ-
ences in response latency were assessed using
Friedman’s test. Differences amongst treatments
were assessed using independent Kruskal–Wallis
tests. Where significant effects were identified, pair-
wise comparisons were conducted to elucidate the
direction of the effect.
Results Cats treated with morphine (v2 = 12.90,
df = 6, p = 0.045) and tramadol (v2 = 20.28,
df = 6, p = 0.002) showed significant increases in
latency to respond. However, subsequent pairwise
comparisons indicated that differences in latencies
at specific time-points were significant (p < 0.05)
only for tramadol at 60–75 and 90–105 minutes
after administration (21.9 and 43.6 seconds,
respectively) in comparison with baseline
(11.0 seconds). No significant pairwise compari-
sons were found within the morphine treatment.
Injections of saline, ketoprofen, medetomidine or
buprenorphine showed no significant effect on
latency to respond.
Conclusions and clinical relevance The CO2 laser
technique may have utility in the assessment of
thermal nociceptive thresholds in pain-free cats after
analgesic administration and may provide a simpler
alternative to existing systems. Further exploration
is required to examine its sensitivity and compara-
tive utility.
Keywords analgesia, behaviour, CO2 lasers, domes-
tic cat, nociception tests.
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Introduction
The domestic cat (Felis catus) was previously con-
sidered to have been underexplored in terms of its
responses to pain and analgesia, but significant
advances have since been made (Robertson 2008).
Evidence suggests that the cat, as a species, displays
substantial variation in its responses to different
classes of analgesic compounds (Taylor et al. 2001;
Robertson & Taylor 2004). Likewise, there appears
to be substantial inter-individual variation in the
effects and pharmacodynamics of specific analgesics,
particularly for opioids (Lascelles & Robertson 2004;
Johnson et al. 2007; Giordano et al. 2010; Steagall
et al. 2013). These differences, as well as variations
in injuries and clinical procedures, make the extrap-
olation of effects from other species, or even between
individuals of the same species, difficult (Steagall &
Monteiro-Steagall 2013). Research into techniques
that allow pain and analgesic effects in cats to be
objectively assessed is therefore prudent.
Thermal assessment techniques have been vali-
dated for use in cats. These include both methods
using contact devices (Dixon et al. 2002) and those
using remote carbon dioxide (CO2) laser stimulation
(Farnworth et al. 2013a). Although methods using
contact devices have been extensively explored and
applied (Robertson et al. 2003; Steagall et al. 2007;
Taylor et al. 2007a), the latter technique has been
validated only in terms of its intra-individual repeat-
ability (Farnworth et al. 2013a) and inter-individ-
ual variability (Farnworth et al. 2013b). It has not
yet been used to explore the effects of pharmacolog-
ical manipulation of nociceptive thresholds.
Research in other species suggests that the CO2
laser may be a valid tool for the assessment of
nociception (Herskin et al. 2003; Guesgen et al.
2011; Di Giminiani et al. 2013), although its ability
to measure variations in pain experienced post-
castration are inconclusive (Ting et al. 2010). The
fact that the laser technique can be potentially used
with only moderate alteration of management
routines and without the substantial need for
habituation required by other techniques (Slingsby
& Taylor 2008; Slingsby et al. 2010) suggests it may
represent a useful tool if validated further.
This research sought to explore the effectiveness of
a CO2 thermal laser for the assessment of nociceptive
thresholds in pain-free cats under analgesia. If this
technique is to be considered useful for the assess-
ment of analgesia, latency to display a behavioural
response should show distinctions among cats
treated with any one of the five compounds known
to have analgesic effects (morphine, buprenorphine,
tramadol, ketoprofen and medetomidine) and a
saline-treated control group. We hypothesized that
latency to respond to thermal stimulation would
differ within the morphine, buprenorphine, tram-
adol and medetomidine treatment groups over the
duration of the test period, but not in cats treated
with saline or ketoprofen, which has peripheral anti-
inflammatory effects. Inflammation was likely to be
absent in these test subjects.
Materials and methods
Cats and housing conditions
All procedures were approved by the Massey Uni-
versity Animal Ethics Committee (MUAEC protocol
12/109). A total of 60 adult female domestic cats
were used, including 32 entire and 28 spayed
animals, with a mean  standard deviation (SD)
weight of 3.3  0.6 kg and age of 6.1  3.1 years.
The cats were permanently housed in a nutritional
research facility in stable colonies of 10 individuals.
Each colony was housed in an outdoor pen (2.4 m in
height, 1.4 m in width, 4.4 m in depth), approxi-
mately half the volume of which was under cover.
Records for the cats included (which were updated
weekly) showed no longterm medical conditions,
abnormal gait or substantial fluctuations in weight.
The cats were therefore considered to be healthy and
pain-free, although no blood analyses were per-
formed to categorically confirm this. As treatment
allocation was determined only shortly before the
commencement of the experiment, food was not
withheld in the colony housing and all subjects were
fed a standard wet cat food diet ad libitum through-
out the trial. Adverse side effects of treatment, such
as excessive salivation or vomiting, were recorded
during the experimental phase.
During testing, cats were individually held in eight
metabolism cages (0.8 m in height, 0.8 m in width,
1.1 m in depth) in a non-climate-controlled room
adjacent to, but separate from, the colony housing
area (see Hendriks et al. 1999). These cages were
regularly used for nutritional trials during which the
cats were isolated and allowed to feed. The cats were
therefore familiar with the cages and single housing,
and thus there was no need to acclimatize the
subjects. Prior to the cat being introduced to the
cage, the depth of each cage was reduced to 0.55 m
using a cardboard wall to ensure the cat did not have
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access to a shelf at the rear of the cage and to prevent
the reflection of the laser from the plastic rear wall.
The metal cage door was replaced with a plasticated
square mesh with 25 9 25 mm openings to prevent
reflection of the laser and subsequent injury to the
subjects or operators. For the cats’ comfort, and to
encourage sternal recumbency, each cage was
furnished with a small wooden box, blanket and
litter tray. Food and water were not provided in the
individual cages during the test phase.
Laser device
Thermal nociceptive thresholds were measured
using a remote laser device (Model 48-1; Synrad,
Inc., WA, USA), which was mounted on a tripod to
allow movement through vertical and horizontal
planes. The CO2 laser produced a beam measuring
3.5 mm in diameter, which was aimed using a non-
thermal visible helium laser (JG-4A Class IIIA,
wavelength 532 nm) attached to the external cas-
ing. The wavelength of the thermal laser was
10.6 lm (far infra-red) and the maximum power
output was 10 W. For the purposes of this experi-
ment, a 5% output was used (500 mW). As the non-
visible component of the laser was potentially
hazardous, safety goggles were employed by the
experimenters at all times.
The visible (non-thermal) helium laser used to
guide the thermal CO2 laser has previously been
demonstrated to have no discernible effect on the
behavioural response latency of cats (Farnworth
et al. 2013a) and hence was not used as a control in
this experiment. In a previous study using cats, all
responses to 500 mW thermal stimulation occurred
in <60 seconds (Farnworth et al. 2013b) and there-
fore 60 seconds was set as the maximum duration
for exposure to the thermal stimulus.
Thermal threshold testing procedure
The study was conducted over 5 days in February
2013. Approximately 24 hours prior to the com-
mencement of testing, each cat’s fur was clipped to
skin level on both sides of the thorax as per the
technique outlined in Farnworth et al. (2013b). The
cats were not removed from their colony cages
during this procedure. For all cats, data on age,
current body weight and whether or not the cat had
been spayed were taken from their records. Each cat
was systematically allocated to one of six treatment
groups by ordering their names alphabetically and
sequentially allocating them to groups 1–6; the
primary researcher (MJF) was blinded to this sys-
tematic approach. Likewise, individuals were sys-
tematically allocated to a test day so that treatments
were distributed across all test days rather than any
single treatment being conducted on any single day.
All tests were conducted between 09.00 and
17.00 hours. The total test period for each group
was approximately 150–165 minutes.
For testing, eight cats from across the treatment
groups were transferred to the experimental cages
and were not returned until all nociceptive tests had
been conducted on all subjects. On introduction to
the test cages, cats were allowed 15 minutes to
settle. The experimenters and equipment remained
in the room during this time to habituate the cats to
their presence. On commencement of the test
sequence, the majority of the cats were quiet and
in sternal recumbency.
Each cat was exposed seven times to a CO2
thermal laser device during the test period. Cats
were not returned to the colony cages between tests.
The laser was directed onto the exposed area of skin
from a distance of 2 m until the cat responded either
by shifting significantly (i.e. rising to its feet or
significantly easing its body) or exhibiting the
panniculus reflex, or until the pre-determined cut-
off time of 60 seconds was reached (Farnworth et al.
2013b). The laser was turned off immediately
following either of these behavioural responses.
The deactivation of the laser device and the timing
of latency to respond were both performed manually
(i.e. the timing device was not intrinsically con-
nected to the laser on/off switch). As this introduced
a margin of error based on the researcher’s reaction
time, the subject’s latency to respond (time) was
noted to the nearest 0.1 second. The researchers
attempted to avoid stimulation of the same area of
skin during subsequent tests on any given subject.
To minimize variations in the distance of the laser
from the cat, a line of tape was placed on the floor
2 m from the front of the cage and the front leg of the
tripod on which the laser was mounted was placed
on this line each time the laser device was moved. In
the event that a cat was disturbed during testing
(e.g. by the actions of an adjacent cat or staff
activity) or moved incidentally (e.g. began to groom
or urinate), the test was terminated and restarted as
soon as possible (i.e. once the cat had resettled).
Following an appropriate response the thermal laser
was not re-applied until a minimum of 15 minutes
had elapsed. The exact time between each test varied
© 2015 Association of Veterinary Anaesthetists and the American College of Veterinary Anesthesia and Analgesia, 42, 638–647 640
Thermal nociceptive thresholds in cats MJ Farnworth et al.
depending upon the activity pattern of the individual
(i.e. time to sternal recumbence).
The first thermal test in each cat was conducted
prior to drug administration to establish a baseline
response. The primary researcher (MJF) then exited
the room to ensure he was blind to treatment and
the appropriate drug was then injected by a qualified
veterinarian (LAB). Latency to respond to thermal
stimulation was measured during the time intervals
15–30, 30–45, 45–60, 60–75, 90–105 and 120–
135 minutes. Intervals, rather than exact time-
points, were used as the cats were unrestrained and
laser line-of-sight could not be guaranteed at any
precise time. Where a reading could not be made
within a 15 minute interval, the data point was
recorded as absent.
Drug treatments
Cats were randomly allocated to one of six treat-
ments by the administering veterinarian, resulting
in 10 cats per treatment group. A sample size of 10
was selected as it concurred with other similar
thermal threshold testing protocols in the literature.
The six treatment groups were: 1) saline (0.2 mL per
cat; 0.9% NaCl; Baxter Healthcare Pty Ltd, New
Zealand); 2) morphine (0.5 mg kg1; morphine
sulphate 10 mg mL1; Hospira Pty Ltd, Australia);
3) buprenorphine (20 lg kg1; Temgesic 0.3 mg
mL1; Reckitt Benckiser Ltd, New Zealand); 4)
medetomidine (2 lg kg1; Domitor 1 mg mL1;
Pfizer Global Pharmaceuticals, New Zealand); 5)
tramadol (2 mg kg1; Tramal 50 mg mL1; CSL
Biotherapies NZ Ltd, New Zealand); and 6) ketopro-
fen (3 mg kg1; Ketofen 10%; Merial New Zealand,
New Zealand). In treatment group 4, a 1:10 dilution
ratio (medetomidine:saline) was used to ensure
injectable volume equivalence among treatments.
All cats received an intramuscular (IM) injection
into the epaxial muscles between the iliac crest and
the last rib. Injection was made using a 22 gauge,
¾ inch needle from a 1 mL syringe.
Statistical analyses
We used IBM SPSS Statistics for Windows Version
22.0 (IBM Corp., NY, USA) to conduct our analysis.
Our data were mostly nonparametric and our
measures of central tendency and variation are
expressed as the median (range). We tested for
differences in weight and age among treatment
groups using a one-way ANOVA procedure. Prior to
testing, we confirmed that data were normally
distributed using the Kolmogorov–Smirnov test.
After testing, we checked for homogeneity of vari-
ance using Levene’s test.
The distribution of latencies to respond to thermal
stimulation were not normal and thus a nonpara-
metric Friedman’s test was used to explore differ-
ences in response times across the duration of the
monitoring period (135 minutes) for each of the
treatments separately. When a subject’s latency to
respond exceeded the 60 second cut-off time, it was
recorded as >60 seconds.
The effect of treatment on latency to respond at a
particular time period (e.g. 15–30 minutes) was
analysed by comparing response latencies amongst
groups for each of the seven time periods using an
independent Kruskal–Wallis test. When a significant
effect was detected across a treatment group, pair-
wise Mann–Whitney tests were conducted to identify
where inter-treatment differences occurred. Given
the large number of potential comparisons, we
restricted these to the period 60–75 minutes after
the injection of the drug or saline. Data for each
treatment group were also compared with data for
the control group at each time-point. We adjusted
the p-values using Bonferroni correction [critical
value for significance (0.05)/number of compari-
sons] to reduce the likelihood of Type 1 errors.
Results
Weight and age
Weight (Levene’s test, F(5,53) = 2.292, p = 0.06)
and age (Levene’s test, F(5,53) = 0.485, p = 0.786)
were homogeneous and normally distributed
(weight: Kolmogorov–Smirnov test, p > 0.2 for each
treatment group; age: Kolmogorov–Smirnov test,
p > 0.074 for each treatment group). No differences
in body weight (F(5,53) = 1.176, p = 0.33) or age
(F(5,53) = 0.278, p = 0.923) were detected among
the treatment groups. Weight and age differences
were disregarded as potential explanations for
different responses among treatments.
Effect of treatments on latency to respond to thermal
stimulation
Readings were unavailable for 15 of 420 data points.
Of these, six data points were absent in the saline
group, four in the ketoprofen group, two in the
medetomidine group, two in the buprenorphine
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group and one in the morphine group. Response
times of cats to thermal stimulation were highly
variable across all six drug treatments (Fig. 1).
However, the median and total range of pre-treat-
ment response times for cats that received either an
analgesic drug or saline solution were always
<60 seconds (Table 1). No significant effects of
treatment with regard to the total test period were
found for the following: saline (v2 = 3.922, df = 6,
p = 0.687); medetomidine (v2 = 3.077, df = 6,
p = 0.799), and ketoprofen (v2 = 5.816, df = 6,
p = 0.444). Although treatment with buprenor-
phine had no significant effect, there was a sugges-
tion that latency to respond increased during the test
phase (v2 = 10.929, df = 6, p = 0.091). By con-
trast, median response times in cats injected with
morphine and buprenorphine exceeded 60 seconds
on at least one of the post-treatment time intervals.
Treatment with morphine (v2 = 12.90, df = 6,
p = 0.045) and tramadol (v2 = 20.28, df = 6,
p = 0.002) had significant effects on latency to
respond over the course of the monitoring period.
Table 2 shows the numbers of tests in which the
60 second cut-off point was reached.
For those analgesics that showed a significant
effect on latency to respond across the duration of
the monitoring period, we conducted a series of
pairwise comparisons. These were used to determine
whether the difference occurred at 30–45 minutes,
double this time (60–75 minutes) or double this
time again (120–135 minutes) in comparison with
the baseline response time. This represented three
pairwise comparisons and the threshold value for
significance was adjusted to p = 0.017.
For tramadol, significant differences in latency
were recorded between the pre-treatment test and
those at 60–75 minutes (Z = 2.803, p = 0.005)
and 120–135 minutes after treatment (Z = 2.803,
p = 0.005). Similarly, we recorded significant differ-
ences in the morphine treatment group between pre-
treatment values and those at 60–75 minutes
(Z = 2.701, p = 0.007) and 120–135 minutes
(Z = 2.599, p = 0.009). We also determined the
magnitude of the effect (effect size r) for these two-
Figure 1 Latency (seconds) of cats
to respond to thermal stimulation
generated by a carbon dioxide laser
across six treatments. Quartiles are
represented by the box and median
latency by the horizontal bar.
Whiskers represent the value at
1.5 times the size of the quartile
box unless the maximum and
minimum values fall within these
values. For both tramadol and
morphine, **denotes a statistically
significant effect across the entire
test period on latency to respond
(p < 0.05). For buprenorphine,
*denotes a statistical trend
(p < 0.1).
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way comparisons (Field 2009). Effect sizes for both
tramadol and morphine were medium to large for
both the pre-test versus 60–75 minutes and pre-test
versus 120–135 minutes comparisons (Table 3).
Effect sizes for buprenorphine fell within the range
of those for tramadol and morphine.
The comparison of latencies to respond amongst
groups at specific time-points indicated there was no
significant effect of treatment on latency to respond to
thermal stimulation during the pre-treatment (v2 =
1.54, df = 5, p = 0.909), 15–30 minutes (v2 = 4.68,
df = 5, p = 0.456) and 30–45 minutes (v2 = 6.669,
df = 5, p = 0.246) intervals. However, significant
effects were detected amongst treatments at 45–
60 minutes (v2 = 12.254, df = 5, p = 0.030), 60–
75 minutes (v2 = 21.02, df = 5, p = 0.001), 90–
105 minutes (v2 = 18.38, df = 5, p = 0.003) and
120–135 minutes (v2 = 11.72, df = 5, p = 0.039).
We followed up on the effect of treatment at the
halfway period of our trials (60–75 minutes) using
Mann–Whitney tests in a series of pairwise compar-
isons.Bonferroni correction resulted in the reportingof
our effects at a significance level of0.01.Therewereno
significant differences in latency to respond between
cats injected with saline and those injected with
buprenorphine (U = 20.0, p = 0.04), medetomidine
(U = 40.0, p = 0.965), tramadol (U = 16.0,
p = 0.017) and ketoprofen (U = 37.0, p = 0.514).
However, the difference in latency to response was
significant when data for cats in the saline treatment
were compared with those for cats in the morphine
treatment (U = 5.0, p = 0.001). Given that the Bon-
ferroni correctionprovides a conservative indication of
significance, determination of an effect size of drug
treatment on latency to respond indicated a medium
effect of buprenorphine (0.47) and tramadol
(0.54) despite the nonsignificant Mann–Whitney
tests. The effect size for ketoprofenwas small (0.149)
and that for medetomidine was negligible (0.01).
Morphine showed a medium to large effect (0.767)
on latency to respond in comparison with saline.
Side effects of treatment and procedure
Side effects associated with the administration of
drugs and the application of the thermal stimulus
were observed and subsequently reported to, and
noted by, the ethics committee concerned with the
approval of these protocols. Firstly, 24 hours after
the experiment, during routine checks, 24 of the 60
cats were found to show signs of mild blistering at
sites at which the laser had been applied. Of the 24T
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cats with blistering, 18 had reached the maximum
exposure time of 60 seconds on one or more
occasion during testing. Blistering was dispersed
across all treatment groups, but was most prevalent
in the morphine, buprenorphine and tramadol
groups (five of 10 individuals). Secondly, there was
evidence of nausea shortly after the administration
of morphine. Eight of the 10 cats in this group
showed signs of excessive salivation or retching.
Discussion
Significant changes in latency to respond to thermal
nociceptive stimulation in the morphine and tram-
adol treatment groups support the proposal that this
technique using a CO2 laser may be useful for
assessing nociceptive thresholds in cats provided
with these analgesic drugs.
The morphine dose used here was comparatively
high. However, as in other studies, such as that by
Steagall et al. (2006), in which 0.2 mg kg1 was
administered subcutaneously (SC), a significant
change in threshold response was observed at
around 60 minutes. A previous study with IM
injection [0.2 mg kg1 (Robertson et al. 2003)]
showed no significant changes in thermal threshold
until 4–6 hours following injection. Epidural admin-
istration [0.1 mg kg1 (Castro et al. 2009)] also
resulted in a significant reduction in nociceptive
response to a tail clamp at 1–12 hours.
Tramadol has been shown to significantly
increase thermal thresholds 45 minutes after SC
administration at 1 mg kg1, but to have otherwise
limited effect (Steagall et al. 2008). Significant
increases in thermal threshold, measured using an
attached device with a heating element, have been
observed to persist for 45–90 minutes following IM
injection of tramadol at a dosage of 2 mg kg1
(Jiwlawat & Durongphongtorn 2011), a finding that
compares well with the results obtained in this
experiment (Table 1). Further studies comparing
different thermal techniques would be beneficial.
Buprenorphine did not demonstrate a clear sig-
nificant effect on thermal nociceptive thresholds.
Studies using intravenous (IV) (Steagall et al.
2009a) and SC (Steagall et al. 2006) administra-
tions of buprenorphine at the dose used in this study
demonstrated a clear effect on thermal threshold
using the thermal device developed by Dixon et al.
(2002) within 15 minutes and 45 minutes, respec-
tively, of administration. The former was effective for
up to 4 hours. Loss of significance across the sample
may result from higher inter-individual variation in
latency to respond to a low output thermal laser
(Fig. 1). Our data suggest that the responses of
individual cats at the same dose may also be highly
variable as some individuals rapidly reached our cut-
off time, whereas others demonstrated relatively
little change across the testing period.
Table 3 Effect sizes for significant pairwise comparisons
Treatment
Pre-test versus
60–75 minutes
Effect size r
Pre-test versus
120–135 minutes
Effect size r
Morphine 0.604 0.572
Tramadol 0.627 0.627
Buprenorphine 0.537 0.604
Values for buprenorphine are included as normal hypotheses
testing indicated significance remained below 0.1. Effect sizes of
0.2 (+ or ) are considered small, those of 0.5 (+ or ) as
medium, and those of 0.8 (+ or ) as large. For group details,
see Table 1.
Table 2 Number of tests (numerator) within a given time period in which subjects (cats) reached the 60 second cut-off time
Treatment
Time phase, minutes
Pre-test 15–30 30–45 45–60 60–75 90–105 120–135
Saline (0.2 mL per cat) 0/10 0/8 0/10 0/7 0/9 0/10 2/10
Morphine (0.5 mg kg1) 0/10 1/9 2/10 4/10 7/10 4/10 4/10
Buprenorphine (20 lg kg1) 0/10 4/9 6/10 5/10 4/10 5/9 3/10
Tramadol (2 mg kg1) 0/10 2/10 1/10 3/10 4/10 5/10 2/10
Ketoprofen (2 mg kg1) 0/10 0/9 0/9 0/9 0/10 1/10 1/9
Medetomidine (2 lg kg1) 0/10 1/9 0/10 1/9 1/10 1/10 2/10
The denominator is the total number of tests obtained for that time period. For group details, see Table 1.
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As expected, no significant effects were found in
groups administered saline or ketoprofen. However,
like other non-steroidal anti-inflammatory drugs
(NSAIDs) [e.g. carprofen (Taylor et al. 2007b)],
ketoprofen is an effective analgesic when adminis-
tered postoperatively (Tobias et al. 2006) but is not
generally expected to have an analgesic effect that
can be elucidated through thermal stimulation in
pain-free cats. This is because NSAID analgesics act
by reducing inflammation and, therefore, nociceptor
activation (Le Bars et al. 2001). This lack of
response to both saline and an NSAID has been
used to validate other emerging nociception assess-
ment techniques in pain-free cats (Steagall et al.
2007). Assessment of absolute pain-free status in the
present subjects did not include specific examina-
tions or blood analyses. Conditions such as degen-
erative joint and renal diseases are more prevalent in
older cats, but may be sub-clinically present in cats
of a range of ages (Marino et al. 2014). Such
conditions may be difficult to diagnose without
thorough blood analyses. It is therefore not possible
to rule out the presence of chronic low-level pain
associated with such diagnoses in some subjects.
However, a lack of nociceptive change in cats
administered ketoprofen suggests a lack of inflam-
matory pain, at least in that treatment group. Two
subjects in the saline group reached the 60 second
cut-off time in the last test phase (see Table 2).
Although aberrant results often occur, it is possible
that the protracted length of the experimental period
in this study in comparison with those in earlier
studies (Farnworth et al. 2013a,b) may have
increased the tendency for non-response.
A significant positive correlation between body
weight and latency to exhibit a behavioural response
has previously been demonstrated using thermal
stimulation (Farnworth et al. 2013b). In addition,
age-related changes in nociceptive sensitivity have
been demonstrated in rodents (Chan & Lai 1982;
Jourdan et al. 2000). Our results indicated that
these factors did not differ significantly between
treatment groups and therefore any variation
amongst subjects attributable to age or weight is
unlikely to impact upon overall latency to respond at
the group level. The test periods used represent a
further limitation in that they were not long enough
to allow for evaluation of the overall effect of the
analgesics. Further exploration of the CO2 laser for
such purposes is required.
In general, our data showed substantial over-
dispersion (see Table 1 and Fig. 1). There were clear
differences in latencies to respond amongst cats
within the same treatment group at a given time-
point. Opioids are known to elicit substantial inter-
individual variability in cats (Taylor et al. 2007c);
this variability has recently been discussed relative
to buprenorphine (Steagall et al. 2014). It is likely
that the over-dispersion of response times explains
why findings in the buprenorphine group did not
achieve statistical significance overall and why the
effects of morphine were not established statistically
through corrected posthoc analysis. However, analy-
sis of effect size did identify that the changes in
response time seen in the tramadol, morphine and
buprenorphine groups were similar. This suggests
that the lack of significance is likely to have been
caused by small sample sizes rather than a lack of
effect. Smaller cohort studies of thermal nociceptive
thresholds commonly use a crossover design, which
functions to minimize inter-individual variability. It
may be judicious to use such a design with a thermal
CO2 laser. This study appears to have been ade-
quately powered to establish differences between
control treatments and analgesic treatments, but it
may not have been sufficiently powered to detect
differences between opioids or to account for a large
degree of inter-individual variation.
Medetomidine showed no significant effect on
thermal thresholds; however, the amount used in
this study was well below that used in other studies
(e.g. Ansah et al. 2002). In part, this was to avoid
excessive levels of sedation, which are known to
impact upon animals’ ability to demonstrate noci-
ceptive response (Hunt et al. 2013). The IM admin-
istration of medetomidine at ≥50 lg kg1 has been
shown to result in peak sedation scores (Ansah et al.
1998) and is often utilized as an adjunctive sedative
during anaesthesia (Wiese & Muir 2007). In cats,
analgesia is achieved with dosages of both
15 lg kg1 and 10 lg kg1(Ansah et al. 2002;
Steagall et al. 2009b). Medetomidine was included
at a substantially lower dosage here (2 lg kg1) in
an attempt to assess the sensitivity of the CO2 laser
protocol. This result suggests that either medetom-
idine had no analgesic or sedative effect at this dose
or that this thermal technique is not able to elucidate
small changes in nociception. Retrospectively, it
appears that a validated dose rate of 10 lg kg1
(Cullen 1996) would have been appropriate.
Although our results appear promising, there are
areas which require further exploration and some
findings indicate potential drawbacks. This tech-
nique lacks the direct contact of attached thermal
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devices and hence, although normal behavioural
patterns are not disrupted, it is difficult to take
measurements at exact time-points because of the
subject’s movement patterns. We were also unable
to ascertain the effect of skin temperature variations
on latency to respond to a remote thermal stimulus.
This is of particular interest because opioids such as
morphine and buprenorphine cause significant
increases in body temperature (Posner et al.
2010), and other drugs such as dexmedetomidine
have been shown to impact upon thermoregulatory
processes (Talke et al. 1997).
It is important to note there was some evidence
of blistering in cats exposed for the full 60 seconds,
possibly as a result of reduced reactivity brought
about by the analgesic and/or sedative effects of
treatment. This effect was not previously observed
in other similar experiments (Farnworth et al.
2013b), but it suggests a need to establish the
time-point at which damage occurs and to reduce
the exposure time accordingly. However, the use of
an earlier cut-off point is likely to require a
statistical technique that can account for higher
numbers of right-censored data points (those
reaching the cut-off point) from cats provided with
analgesics. Although we attempted to minimize the
likelihood that a single point of stimulation would
be reused, our inability to definitively ensure this
may have resulted in some sensitization to the
thermal stimulus. Future exploration may include
marking the site of each test to be undertakenon
the subject’s skin with ink. Targeting of the mark
with the visible laser would preclude the uninten-
tional overlap of stimulation sites.
Future studies using this technique should
attempt to measure sedation and perhaps address
a narrower array of analgesics using a broader set
of dose rates. They may also wish to address how
this technique applies to analgesia following surgi-
cal interventions and in animals already experi-
encing pain. It would also be useful to develop this
technique in conjunction with thermographic
imaging to quantify any effects of changes in skin
temperature resulting from external temperature
fluctuations or physiological changes as a result of
drug administration. It is reasonable to conclude
that the research hypotheses were supported by
our findings and that a CO2 laser is able to
determine changes in antinociceptive thresholds in
cats tested following the administration of opioids.
The utility of this technique warrants further
exploration.
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